MedTrace Logo

Intensive Insulin Treatment and Ischemic Foot Ulcer

NCT01957930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2020-09-29

Study results available
· View outcomes & findings →

Summary

We aim to investigate the relationship between skin microvascular function and the first hospitalization for ischemic foot ulcer in patients with type 1 diabetes former randomized during 7.5 years to intensified conventional insulin treatment (ICT) compared to standard insulin treatment (ST).

Conditions

  • Ischemic Foot Ulcer

Interventions

DRUG

Intensified insulin treatment

The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.

DRUG

Standard treatment

Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months

Sponsors & Collaborators

Principal Investigators

  • Thomas Nyström, MD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1984-01-31
Primary Completion
2011-12-31
Completion
2013-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01957930 on ClinicalTrials.gov